Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Akero Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee (1) |
Carry Forward Type |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Fees to Be Paid |
Equity | Common Stock, $0.0001 par value per share |
Rule 457(r) | 12,650,000 | $29.00 | $366,850,000 | 0.00014760 | $54,147.06 | — | — | — | — | ||||||||||||
| Fees Previously Paid |
||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||
| Total Offering Amounts | $366,850,000 | $54,147.06 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $54,147.06 | |||||||||||||||||||||||
| (1) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended. Represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (Registration No. 333-256229) being paid herewith. |